VLDLR and atherosclerosis: They also increase non-HDL-C and LDL clearance by promoting the expression of low-density lipoprotein receptors concentrated in hepatocytes,23,24 which is an important means to reduce ASCVD events,25, 26, 27 and effectively reduce the risk of recurrent cerebral infarction.28